Search

Your search keyword '"Desonide"' showing total 13 results
Start Over Descriptor "Desonide" Journal accord fintech
13 results on '"Desonide"'

1. Alembic Pharmaceuticals gets USFDA's final approval for Desonide Cream

Subjects
United States. Food and Drug Administration, Drug approval, Topical medication, Desonide, Business, international
Abstract

The ANDA was filed by Aleor Dermaceuticals which was amalgamated with Alembic Alembic Pharmaceuticals (Alembic) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated [...]

Published
2022

2. Alembic Pharmaceuticals' JV gets USFDA's final nod for Desonide Lotion

Subjects
United States. Food and Drug Administration, Desonide, Drug approval, Company joint venture, Business, international
Abstract

The company has a cumulative total of 129 ANDA approvals from USFDA Alembic Pharmaceuticals' joint venture (JV) Aleor Dermaceuticals (Aleor) has received final approval from the US Food & Drug [...]

Published
2020

4. Cadila Healthcare submits press release

Subjects
Nitrates, Topical drugs, Isosorbide dinitrate, Desonide, Business, international
Abstract

Cadila Healthcare has informed about submission of a copy of press release dated November 21, 2019 titled 'Zydus receives final approvals from the USFDA for Isosorbide Dinitrate Tablets and Desonide [...]

Published
2019

5. Zydus Cadila gets USFDA's nod for Isosorbide Dinitrate Tablets, Desonide Cream

Subjects
United States. Food and Drug Administration, Cadila Healthcare Ltd., Desonide, Pharmaceutical industry, Drug approval, Topical drugs, Isosorbide dinitrate, Nitrates, Chest pain, Angina pectoris, Business, international
Abstract

The group now has 278 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04 Zydus Cadila has received the final [...]

Published
2019

6. Alembic Pharma's JV gets USFDA's nod for Desonide Ointment

Subjects
United States. Food and Drug Administration, Desonide, Drug approval, Topical drugs, Corticosteroid drugs, Glucocorticoids, Company joint venture, Business, international
Abstract

Desonide Ointment, 0.05%, has an estimated market size of $13 million for twelve months ending December 2018 Alembic Pharmaceuticals' joint venture (JV) Aleor Dermaceuticals (Aleor) has received approval from US [...]

Published
2019

7. Alembic Pharma shines as its JV gets USFDA's nod for Desonide Ointment

Subjects
United States. Food and Drug Administration, Desonide, Topical drugs, Company joint venture, Business, international
Abstract

Desonide Ointment, 0.05%, has an estimated market size of $13 million for twelve months ending December 2018 Alembic Pharmaceuticals is currently trading at Rs. 544.05, up by 6.85 points or [...]

Published
2019

8. Glenmark receives USFDA approval for Desonide Lotion

Subjects
United States. Food and Drug Administration, Desonide, Drug approval, Business, international
Abstract

The Desonide Lotion, 0.05% market achieved annual sales of approximately $23.2 million Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration [...]

Published
2017

9. Glenmark receives final approval from USFDA for Desonide Ointment

Subjects
United States. Food and Drug Administration, Desonide, Generic drugs, Drug approval, Topical drugs, Business, international
Abstract

The Desonide Ointment, 0.05% market achieved annual sales of approximately $23.4 million Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration [...]

Published
2017

10. Glenmark rises on receiving final approval from USFDA for Desonide Ointment

Subjects
United States. Food and Drug Administration, Desonide, Topical drugs, Business, international
Abstract

The Desonide Ointment, 0.05% market achieved annual sales of approximately $23.4 million Glenmark Pharmaceuticals is currently trading at Rs. 615.60, up by 8.65 points or 1.43% from its previous closing [...]

Published
2017

11. Glenmark Pharmaceuticals trades higher on the bourses

Subjects
United States. Food and Drug Administration, Desonide, Pharmaceutical industry, Business, international
Abstract

The pharma major has received final approval from USFDA for Desonide Cream Glenmark Pharmaceuticals is currently trading at Rs. 736.75, up by 21.00 points or 2.93% from its previous closing [...]

Published
2017

12. Glenmark gains on receiving final approval from USFDA for Desonide Cream

Subjects
United States. Food and Drug Administration, Desonide, Topical drugs, Business, international
Abstract

The Desonide Cream, 0.05% market achieved annual sales of approximately $44.6 million Glenmark Pharmaceuticals is currently trading at Rs. 693.60, up by 4.70 points or 0.68% from its previous closing [...]

Published
2017

13. Glenmark receives final approval from USFDA for Desonide Cream

Subjects
United States. Food and Drug Administration, Desonide, Generic drugs, Drug approval, Topical drugs, Business, international
Abstract

The Desonide Cream, 0.05% market achieved annual sales of approximately $44.6 million Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration [...]

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results